GAFFX
Price
$72.65
Change
-$0.09 (-0.12%)
Updated
May 9 closing price
Net Assets
285.87B
VAFIX
Price
$28.69
Change
-$0.10 (-0.35%)
Updated
May 9 closing price
Net Assets
15.25B
Ad is loading...

GAFFX vs VAFIX

Header iconGAFFX vs VAFIX Comparison
Open Charts GAFFX vs VAFIXBanner chart's image
American Funds Growth Fund of Amer F3
Price$72.65
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets285.87B
Invesco American Franchise Y
Price$28.69
Change-$0.10 (-0.35%)
VolumeN/A
Net Assets15.25B
GAFFX vs VAFIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. VAFIX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and VAFIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 286B vs. VAFIX (15.3B). GAFFX pays higher dividends than VAFIX: GAFFX (0.70) vs VAFIX (0.00). GAFFX was incepted earlier than VAFIX: GAFFX (8 years) vs VAFIX (20 years). VAFIX (0.71) is less costly to investors than GAFFX (0.30). VAFIX is a more actively managed with annual turnover of: 51.00 vs. GAFFX (25.00). VAFIX has a lower initial minimum investment than GAFFX: VAFIX (1000) vs GAFFX (1000000). VAFIX annual gain was more profitable for investors over the last year : 5.69 vs. GAFFX (3.51). GAFFX return over 5 years is better than : 46.03 vs. VAFIX (24.90).
GAFFXVAFIXGAFFX / VAFIX
Total Expense Ratio0.300.7142%
Annual Report Gross Expense Ratio0.300.7142%
Fund Existence8 years20 years-
Gain YTD-2.444-7.66532%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets286B15.3B1,869%
Annual Yield % from dividends0.700.00-
Returns for 1 year3.515.6962%
Returns for 3 years34.0844.5377%
Returns for 5 years46.0324.90185%
Returns for 10 yearsN/A65.75-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
PENN15.640.35
+2.29%
PENN Entertainment
CRL138.79-2.57
-1.82%
Charles River Laboratories International
ACRS1.26-0.05
-3.82%
Aclaris Therapeutics